Expression and regulation of the Δn and TAp63 isoforms in salivary gland tumorigenesis: Clinical and experimental findings

American Journal of Pathology

Volumn 179, Issue 1, 2011, Pages 391-399

  Mitani, Yoshitsugu ^a   Li, Jie ^a   Weber, Randal S ^a   Lippman, Scott L ^a   Flores, Elsa R ^a   Caulin, Carlos ^a   El Naggar, Adel K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PROTEIN DELTA NP63; PROTEIN P63; PROTEIN TAP63; UNCLASSIFIED DRUG;

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; BASAL CELL; CARCINOGENESIS; CELL AGING; CELL INVASION; CELL MIGRATION; CELL MOTILITY; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ECTODERM; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MYOEPITHELIOMA; MYOEPITHELIUM CELL; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; SALIVARY GLAND CARCINOMA; TRANSACTIVATION; WARTHIN TUMOR;

ADENOCARCINOMA; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; WOUND HEALING;

EID: 80052434596     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.03.037     Document Type: Article

References (57)

1. J.A. Pinkston, and P. Cole Incidence rates of salivary gland tumors: results from a population-based study Otolaryngol Head Neck Surg 120 1999 834 840
2. P.M. Speight, and A.W. Barrett Salivary gland tumours Oral Dis 8 2002 229 240
3. C.H. Terhaard, H. Lubsen, I. Van der Tweel, F.J. Hilgers, W.M. Eijkenboom, H.A. Marres, R.E. Tjho-Heslinga, J.M. de Jong, J.L. Roodenburg Dutch Head and Neck Oncology Cooperative Group Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastasis, and overall survival: results of the Dutch head and neck oncology cooperative group Head Neck 26 2004 681 692 discussion, 692693
4. T.A. Day, J. Deveikis, M.B. Gillespie, J.K. Joe, B. Ogretmen, J.D. Osguthorpe, S.G. Reed, M.S. Richardson, M. Rossi, R. Saini, A.K. Sharma, and R.K. Stuart Salivary gland neoplasms Carr Treat Options Oncol 5 2004 11 26
5. L.P. Bron, S.J. Traynor, E.B. McNeil, and C.J. O'Brien Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases Laryngoscope 113 2003 1070 1075
6. J.G. Batsakis, J.A. Regezi, M.A. Luna, and A. El-Naggar Histogenesis of salivary gland neoplasms: a postulate with prognostic implications J Laryngol Otol 103 1989 939 944
7. D. Bell, D. Roberts, M. Kies, P. Rao, R.S. Weber, and A.K. El-Naggar Cell-type dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications Cancer 116 2010 5749 5756
8. S.H. Barsky, and N.J. Karlin Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression J Mammary Gland Biol Neoplasia 10 2005 249 260
9. M. Hu, J. Yao, D.K. Carroll, S. Weremowicz, H. Chen, D. Carrasco, A. Richardson, S. Violette, T. Nikolskaya, Y. Nikolsky, E.L. Bauerlein, W.C. Hahn, R.S. Gelman, C. Allred, M.J. Bissell, S. Schnitt, and K. Polyak Regulation of in situ to invasive breast carcinoma transition Cancer Cell 13 2008 394 406
10. M. Barbareschi, L. Pecciarini, M.G. Cangi, E. Macri, A. Rizzo, G. Viale, and C. Doglioni p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast Am J Surg Pathol 25 2001 1054 1060
11. H. Bilal, A. Handra-Luca, J.C. Bertrand, and P.J. Fouret P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues J Histochem Cytochem 51 2003 133 139
12. Y.K. Chen, S.S. Hsue, and L.M. Lin Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas Int J Oral Maxillofac Surg 33 2004 493 497
13. M. Chilosi, A. Zam, A. Brighenti, G. Malpeli, L. Montagna, P. Piccoli, S. Pedron, M. Lestani, G. Inghirami, A. Scarpa, C. Doglioni, and F. Menestrina Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours Virchows Arch 443 2003 175 183
14. H.R. Choi, J.G. Batsakis, F. Zhan, E. Sturgis, M.A. Luna, and A.K. El-Naggar Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis Hum Pathol 33 2002 158 164
15. P.C. Edwards, T. Bhuiya, and R.D. Kelsch Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 2004 613 619
16. T. Crook, J.M. Nicholls, L. Brooks, J. O'Nions, and M.J. Allday High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 19 2000 3439 3444
17. P.A. Hall, A.C. Woodman, S.J. Campbell, and N.A. Shepherd Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein Gut 49 2001 618 623
18. K. Hibi, B. Trink, M. Patturajan, W.H. Westra, O.L. Caballero, D.E. Hill, E.A. Ratovitski, J. Jen, and D. Sidransky AIS is an oncogene amplified in squamous cell carcinoma Proc Natl Acad Sci U S A 97 2000 5462 5467
19. M.S. Irwin, and W.G. Kaelin p53 family update: p73 and p63 develop their own identities Cell Growth Differ 12 2001 337 349
20. M.C. Marin, and W.G. Kaelin Jr p63 and p73: old members of a new family Biochim Biophys Acta 1470 2000 M93 M100
21. A.A. Mills p63: oncogene or tumor suppressor? Curr Opin Genet Dev 16 2006 38 44
22. M. Osada, M. Ohba, C. Kawahara, C. Ishioka, I. Katoh, Y. Ikawa, Y. Nimura, A. Nakagawara, M. Obinata, and S. Ikawa Cloning and functional analysis of human p51, which structurally and functionally resembles p53 Nat Med 4 1998 839 843
23. Y.P. Huang, G. Wu, Z. Guo, M. Osada, T. Fomenkov, H.L. Park, B. Trink, D. Sidransky, A. Fomenkov, and E.A. Ratovitski Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype Cell Cycle 3 2004 1587 1596
24. C.J. Di Como, M.J. Urist, I. Babayan, M. Drobnjak, C.V. Hedvat, J. Teruya-Feldstein, K. Pohar, A. Hoos, and C. Cordon-Cardo p63 expression profiles in human normal and tumor tissues Clin Cancer Res 8 2002 494 501
25. A.A. Mills, B. Zheng, X.J. Wang, H. Vogel, D.R. Roop, and A. Bradley p63 is a p53 homologue required for limb and epidermal morphogenesis Nature 398 1999 708 713
26. M.I. Koster, and D.R. Roop The role of p63 in development and differentiation of the epidermis J Dermatol Sci 34 2004 3 9
27. U.M. Moll, S. Erster, and A. Zaika p53, p63 and p73: solos, alliances and feuds among family members Biochim Biophys Acta 1552 2001 47 59
28. J.T. O'Connell, G.L. Mutter, A. Cviko, M. Nucci, B.J. Quade, H.P. Kozakewich, E. Neffen, D. Sun, A. Yang, F.D. McKeon, and C.P. Crum Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63 Gynecol Oncol 80 2001 30 36
29. G. Pellegrini, E. Dellambra, O. Golisano, E. Martinelli, I. Fantozzi, S. Bondanza, D. Ponzin, F. McKeon, and M. Le Luca p63 identifies keratinocyte stem cells Proc Natl Acad Sci U S A 98 2001 3156 3161
30. A. Yang, M. Kaghad, Y. Wang, E. Gillett, M.D. Fleming, V. Dotsch, N.C. Andres, D. Caput, and F. McKeon p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Mol Cell 2 1998 305 316
31. A. Yang, R. Schweitzer, D. Sun, M. Kaghad, N. Walker, R.T. Bronson, C. Tabin, A. Sharpe, D. Caput, C. Crum, and F. McKeon p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development Nature 398 1999 714 718
32. P. Ghioni, F. Bolognese, P.H. Duijf, H. Van Bokhoven, R. Mantovani, and L. Guerrini Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains Mol Cell Biol 22 2002 8659 8668
33. K. Nylander, P.J. Coates, and P.A. Hall Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions Int J Cancer 87 2000 368 372
34. K. Polyak, and M. Hu Do myoepithelial cells hold the key for breast tumor progression? J Mammary Gland Biol Neoplasia 10 2005 231 247
35. M.I. Koster, S.L. Lu, L.D. White, X.J. Wang, and D.R. Roop Reactivation of developmentally expressed p63 isoforms predisposes to tumor development and progression Cancer Res 66 2006 3981 3986
36. B.J. Park, S.J. Lee, J.I. Kim, S.J. Lee, C.H. Lee, S.G. Chang, J.H. Park, and S.G. Chi Frequent alteration of p63 expression in human primary bladder carcinomas Cancer Res 60 2000 3370 3374
37. G. Pruneri, L. Pignataro, M. Manzotti, N. Carboni, D. Ronchetti, A. Neri, B.M. Cesana, and G. Viale p63 in laryngeal squamous cell carcinoma: evidence for a role of TA-p63 down-regulation in tumorigenesis and lack of prognostic implications of p63 immunoreactivity Lab Invest 82 2002 1327 1334
38. R.B. Shah, M. Zhou, M. LeBlanc, M. Snyder, and M.A. Rubin Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer Am J Surg Pathol 26 2002 1161 1168
39. S. Signoretti, D. Waltregny, J. Dilks, B. Isaac, D. Lin, L. Garraway, A. Yang, R. Montironi, F. McKeon, and M. Loda p63 is a prostate basal cell marker and is required for prostate development Am J Pathol 157 2000 1769 1775
40. P.P. Massion, P.M. Taflan, S.M. Jamshedur Rahman, P. Yildiz, Y. Shyr, M.E. Edgerton, M.D. Westfall, J.R. Roberts, and J.A. Pietenpol Significance of p63 amplification and overexpression in lung cancer development and prognosis Cancer Res 63 2003 7113 7121
41. F. Koga, S. Kawakami, J. Kumagai, T. Takizawa, N. Ando, G. Arai, Y. Kageyama, and K. Kihara Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms Br J Cancer 88 2003 740 747
42. G. Wu, S. Nomoto, M.O. Hoque, T. Dracheva, M. Osada, C.C. Lee, S.M. Dong, A. Guo, N. Benoit, T. Cohen, P. Rechthand, J. Califano, C.S. Moon, E. Ratovitski, J. Jen, D. Sidransky, and B. Trink DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development Cancer Res 63 2003 2351 2357
43. M. Patturajan, S. Nomoto, M. Sommer, A. Fomenkov, K. Hibi, R. Zangen, N. Poliak, J. Califano, B. Trink, E. Ratovitski, and D. Sidransky DeltaNp63 induces beta-catenin nuclear accumulation and signaling Cancer Cell 1 2002 369 379
44. N. Thurfjell, P.J. Coates, T. Uusitalo, D. Mahani, E. Dabelsteen, A. Dahlqvist, B. Sjostrom, G. Roos, and K. Nylander Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck Int J Oncol 25 2004 27 35
45. M. Herfs, P. Hubert, M. Suarez-Carmona, A. Reschner, S. Saussez, G. Berx, P. Savagner, J. Boniver, and P. Delvenne Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma Am J Pathol 176 2010 1 9
46. M. Senoo, Y. Matsumura, and S. Habu TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression Oncogene 21 2002 2455 2465
47. E.A. Ratovitski, M. Patturajan, K. Hibi, B. Trink, K. Yamaguchi, and D. Sidransky p53 associates with and targets Delta Np63 into a protein degradation pathway Proc Natl Acad Sci U S A 98 2001 1817 1822
48. K. Yamaguchi, L. Wu, O.L. Caballero, K. Hibi, B. Trink, V. Resto, P. Cairns, K. Okami, W.M. Koch, D. Sidransky, and J. Jen Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma Int J Cancer 86 2000 684 689
49. A. Weber, U. Bellmann, F. Bootz, C. Wittekind, and A. Tannapfel Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck Int J Cancer 99 2002 22 28
50. J.S. Reis-Filho, B. Torio, A. Albergaria, and F.C. Schmitt p63 expression in normal skin and usual cutaneous carcinomas J Cutan Pathol 29 2002 517 523
51. H. van Bokhoven, and H.G. Brunner Splitting p63 Am J Hum Genet 71 2002 1 13
52. X. Su, D. Chakravarti, M.-S. Cho, L. Liu, Y.-J. Gi, Y-.L. Lin, M.L. Leung, A.K. El-Naggar, C.J. Creighton, M.B. Suraokar, I. Wistuba, and E.R. Flores TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs Nature 467 2010 986 990
53. X. Guo, W.M. Keyes, C. Papzoglu, J. Zuber, W. Li, S.W. Lowe, H. Vogel, and A.A. Mills TAp63 induces senescence and suppresses tumorigenesis in vivo Nat Cell Biol 11 2009 1451 1458
54. M.S. Jung, J. Yun, H.D. Chae, J.M. Kim, S.C. Kim, T.S. Choi, and D.Y. Shin p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor Oncogene 20 2001 5818 5825
55. R. Zangen, E. Ratovitski, and D. Sidransky DeltaNp63x levels correlate with clinical tumor response to cisplatin Cell Cycle 4 2005 1313 1315
56. A. Fomenkov, R. Zangen, Y.P. Huang, M. Osada, Z. Guo, T. Fomenkov, B. Trink, D. Sidransky, and E.A. Ratovitski RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage Cell Cycle 3 2004 1285 1295
57. C.O. Leong, N. Vidnovic, M.P. DeYoung, D. Sgroi, and L.W. Ellisen The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers J Clin Invest 117 2007 1370 1380